Llwytho...
Targeting insulin-degrading enzyme to treat type 2 diabetes
Insulin degrading enzyme (IDE) selectively degrades peptides such as insulin, amylin, and amyloid β (Aβ) that form toxic aggregates, to maintain proteostasis. IDE defects are linked to the development of type 2 diabetes mellitus (T2DM) and Alzheimer’s disease (AD). Structural and biochemical analyse...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Trends Endocrinol Metab |
|---|---|
| Prif Awdur: | |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2015
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4698235/ https://ncbi.nlm.nih.gov/pubmed/26651592 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tem.2015.11.003 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|